News and Trends 8 Jun 2020 UK Startup Launches with €10M to Detect Epigenetic Signs of Cancer in Blood A seed round of €10.1M will fund the launch of the University of Oxford spinout Base Genomics, which aims to improve cancer detection by measuring epigenetic changes to tumor DNA circulating in the blood. The company’s oversubscribed seed funding round was led by Oxford Sciences Innovation, a local early-stage investment firm linked to the University […] June 8, 2020 - 3 minutesmins - By David Kirk Share WhatsApp Twitter Linkedin Email
Startup Scout 1 May 2020 Belgian Company Harnesses Lab-on-a-Chip Technology to Diagnose Disease The Belgian startup miDiagnostics is developing technology to diagnose diseases quickly, accurately, and at the point-of-care using a silicon lab-on-a-chip and nanoscale-precision microfluidics. Having good diagnostics in place can save lives. This principle is especially true in times of crisis, such as the current coronavirus pandemic. However, producing good diagnostics isn’t a simple task. In […] May 1, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2020 Novacyt Launches Two-Hour Coronavirus Test After FDA Approval The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily transportable test for the coronavirus disease COVID-19. The company is also rolling out the kit this week via manufacturing and distribution partnerships across Europe. The test received an Emergency Use Authorization from the FDA, which means it can only be […] March 26, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2020 Immune Marker in Blood May Predict Kidney Transplant Rejection Risk French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […] March 13, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
Startup Scout 6 Mar 2020 This Startup Is Developing a DIY Biomarker Diagnostics Kit The Swedish medical device startup Qlife is developing a diagnostic kit that patients can use at home to better control chronic diseases. Mission: To make convenient diagnostics for patients with a home-use kit that they can use to monitor blood biomarkers in chronic conditions such as arthritis. Chronic disorders such as cardiovascular disease and diabetes […] March 6, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Mar 2020 CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout UK cell culture specialist CN Bio Innovations has secured €7.98M (£7M) from Chinese investors to bolster its US market and expand European activities. Investment in the bioengineering company was led by Chinese investor CITIC Securities Company and with further support from existing Hong Kong-based investor CN Innovations Holdings. CN Bio, which creates benchtop instruments to […] March 4, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2020 Lasers Used To Make Rapid Antibiotic Resistance Test Researchers from the University of Southampton in the UK have used laser technology to create a paper-based test that can identify bacteria in a urine sample and tell whether the species is showing antibiotic resistance. Urinary tract infections (UTIs) are the most commonly diagnosed infections worldwide and are typically caused by bacteria such as Escherichia […] February 28, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 18 Feb 2020 OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […] February 18, 2020 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 11 Feb 2020 French Biotech Raises €20M to Make Precision Molecular Diagnostics Stilla Technologies has raised a €20M Series C round to fund its mission to produce next-generation microchips that make molecular diagnostics more precise and user-friendly than currently available lab technology. Contributors to the round included Stilla’s existing investors, such as Illumina Ventures, Kurma Partners and Idinvest Partners. Stilla also added the Chinese company TUS-Holdings to […] February 11, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jan 2020 Austrian Genomics Company Joins Fight Against Coronavirus Ares Genetics will use next-generation sequencing technology from the Chinese genomics company BGI Group to track and control the spread of a new coronavirus originating in China. A new strain of coronavirus, dubbed 2019-nCoV and originating in the Chinese city of Wuhan, has caused widespread concern in recent weeks. While only 20% of people with […] January 30, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2020 €6M Seed Round to Develop First Urine Test for Kidney Cancer The Swedish biotech Elypta has raised a seed round worth €6.1M to fund a clinical trial of a urine test for signs of recurrent kidney cancer, which could improve patient follow-up after surgery. The seed round was led by the Swedish VC firm Industrifonden. Other investors in the round included the VC impact fund of […] January 24, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 7 Nov 2019 €51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock Exchange to fund the development of diagnostics technology that could improve the treatment of rare diseases. The fundraise fell under Centogene’s target value of €54M ($60M). A part of the proceeds will fuel the development of biomarkers that Centogene will […] November 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email